In 2009, Shandong Pharmaceutical Glass Company achieved a sales income of 124 million yuan, an increase of 7.24% year-on-year, and an operating profit of 178 million yuan, a year-on-year increase of 25%. The company's domestic business remained stable. However, due to the decline in overseas demand, the growth rate of the company’s main breed brown bottle declined, affecting the company’s growth rate. Although the company is a leading company in the glass packaging industry in China, the traditional glass packaging materials are already in a mature period. In the future, the growth of the company may still depend on the introduction of new products. Recently, the company mainly focuses on the introduction of new bio bottle companies. As the increase in raw materials and energy in 2009 has dropped significantly, the gross profit margin of all products of the company has increased significantly, and the overall gross profit rate of the company has increased by 2.6 percentage points, which has contributed a lot to the growth of the company's performance. The company’s bills receivable and accounts receivable totaled 600 million yuan, accounting for 30% of the company’s total assets. The company’s turnover rate was not high, but the company’s operating cash flow of RMB 250 million was realized in 2009, which is the only higher level in recent years. In the year of net profit, the quality of corporate earnings has improved.